Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: BLCO ALC GKOS ESTA RXST INMD GMED EW BSX MDT

| Held by: IJR VTI IWM VB VXF SPSM VBK IWO IJT SCHA

Index	RUT
Market Cap	1.25B
Enterprise Value	1.10B
Income	3.84M
Sales	339.59M
Book/sh	7.29
Cash/sh	3.62
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	957
IPO	Jul 07, 1983

P/E	374.14
Forward P/E	46.04
PEG	-
P/S	3.67
P/B	3.41
P/C	6.87
P/FCF	-
EV/EBITDA	15.57
EV/Sales	3.25
Quick Ratio	4.03
Current Ratio	4.66
Debt/Eq	0.10
LT Debt/Eq	0.08
Option/Short	Yes / Yes

EPS (ttm)	0.07
EPS next Y	0.54
EPS next Q	0.05
EPS this Y	128.43%
EPS next Y	90.07%
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	-5.57% 7.93%
EPS Y/Y TTM	103.91%
Sales Y/Y TTM	51.30%
EPS Q/Q	146.10%
Sales Q/Q	111.04%
Earnings	Aug 12 AMC
EPS/Sales Surpr.	-27.73% 3.24%

Insider Own	39.81%
Insider Trans	3.47%
Inst Own	73.04%
Inst Trans	-5.87%
ROA	0.84%
ROE	1.09%
ROIC	0.97%
Gross Margin	74.76%
Oper. Margin	18.00%
Profit Margin	1.13%
SMA20	2.63%
SMA50	-6.28%
SMA200	2.69%
Trades

Shs Outstand	50.12M
Shs Float	30.18M
Short Float	16.49%
Short Ratio	5.65
Short Interest	4.98M
52W High	35.87 -30.64%
52W Low	15.59 59.64%
Volatility	7.13% 5.79%
ATR (14)	1.38
RSI (14)	48.33
Beta	1.23
Rel Volume	0.01
Avg Volume	880.63K
Volume	302

Perf Week	-2.09%
Perf Month	2.51%
Perf Quarter	-23.68%
Perf Half Y	41.69%
Perf YTD	7.75%
Perf Year	-11.02%
Perf 3Y	-42.21%
Perf 5Y	-82.05%
Perf 10Y	174.01%
Recom	2.82
Target Price	28.44
Prev Close	24.64
Price	24.88
Change %	0.97%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-28-26	Initiated	UBS	Sell	$20
May-14-26	Upgrade	Wedbush	Neutral → Outperform	$40
Apr-09-26	Upgrade	Canaccord Genuity	Hold → Buy	$27
Feb-03-26	Initiated	Wedbush	Neutral	$26
Jan-16-26	Resumed	Morgan Stanley	Underweight	$13
Apr-21-25	Initiated	Wells Fargo	Equal Weight	$17
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral	$45 → $17
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$50 → $37
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy	$46
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral

Show Previous Ratings

Aug-13-26 08:30AM	STAAR Surgical Company Q2 2026 Earnings Call Summary (Moby)
01:04AM	Staar Surgical Co (STAA) (Q2 2026) Earnings Call Highlights: Record Revenue Surge and Strategic ... (GuruFocus.com)
Aug-12-26 04:07PM	Clarification: Earns-Staar Surgical story (Associated Press)
04:01PM	STAAR Surgical Reports Second Quarter 2026 Results (Business Wire)
Aug-05-26 06:00AM	STAAR Surgical appoints Warren Foust as permanent CEO (MedTech Dive) -5.22%
04:05PM	Loading…
Aug-04-26 04:05PM	STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer (Business Wire)
04:01PM	STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026 (Business Wire)
Jul-16-26 04:01PM	STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026 (Business Wire) -8.76%
May-21-26 04:01PM	STAAR Surgical Announces Participation in Upcoming Investor Conferences (Business Wire)
May-20-26 03:33PM	STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1 (Investing.com)
May-14-26 09:45AM	Starbucks upgraded, Doximity downgraded: Wall Street's top analyst calls (The Fly) +8.88%
01:03AM	Staar Surgical Co (STAA) Q1 2026 Earnings Call Highlights: Record Sales Surge and Return to ... (GuruFocus.com)
May-13-26 04:13PM	Staar Surgical: Q1 Earnings Snapshot (Associated Press)
04:01PM	STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter (Business Wire)
May-04-26 04:01PM	STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026 (Business Wire)
01:32PM	Loading…
Apr-09-26 01:32PM	STAAR Surgical Shares Jump 25% on Blowout $90M Sales Outlook (GuruFocus.com) +20.74%
06:26AM	These Stocks Are Today's Movers: Nvidia, Chevron, Applied Digital, Staar, and More (Barrons.com)
Apr-08-26 04:01PM	STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026 (Business Wire)
Mar-17-26 06:57AM	Alcon abandons effort to purchase LENSAR after FTC scrutiny (MedTech Dive)
Mar-04-26 08:30AM	STAAR Surgical Company Q4 2025 Earnings Call Summary (Moby)
12:02AM	Staar Surgical Co (STAA) Q4 2025 Earnings Call Highlights: Strong Sales Growth in China and ... (GuruFocus.com)
Mar-03-26 07:02PM	STAAR Surgical Q4 Earnings Call Highlights (MarketBeat)
05:15PM	Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates (Zacks)
04:34PM	STAAR Surgical (NASDAQ:STAA) Misses Q4 CY2025 Sales Expectations, Stock Drops 11.2% (StockStory)
04:21PM	Staar Surgical: Q4 Earnings Snapshot (Associated Press Finance)
04:02PM	STAAR Surgical Issues Shareholder Letter (Business Wire)
04:01PM	STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results (Business Wire)
Mar-02-26 09:36AM	Cooper Companies to Post Q1 Earnings: Is a Beat in the Offing? (Zacks)
Feb-26-26 05:30PM	Dentsply International (XRAY) Q4 Earnings Miss Estimates (Zacks)
Feb-25-26 04:01PM	STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction (Business Wire)
12:31PM	Loading…
Feb-24-26 12:31PM	Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy? (Zacks) +8.52%
08:31AM	BrightSpring to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-23-26 04:01PM	STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026 (Business Wire)
08:46AM	DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
08:45AM	Solventum to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-19-26 12:08PM	STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years (Zacks)
Feb-18-26 05:18AM	FDA Expands Approval For Staar Surgical's Popular Implantable Lens (Benzinga) +8.40%
Feb-17-26 04:01PM	FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction (Business Wire)
Feb-09-26 11:37PM	1 Cash-Heavy Stock on Our Watchlist and 2 We Brush Off (StockStory)
Feb-05-26 10:00AM	West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy? (Zacks)
07:55AM	Cardinal Health (CAH) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Feb-04-26 01:27PM	STAAR Surgical Company (STAA): A Bull Case Theory (Insider Monkey)
Feb-03-26 10:00AM	Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
09:34AM	Adobe downgraded, Palantir upgraded: Wall Street's top analyst calls (The Fly)
05:23AM	STAAR names interim co-CEOs amid search for permanent leader (MedTech Dive)
Feb-02-26 12:55PM	Why STAAR Surgical (STAA) Stock Is Trading Lower Today (StockStory)
07:00AM	STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs (Business Wire)
Jan-30-26 01:00PM	Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems (Benzinga)
Jan-25-26 08:18PM	Analysts Question STAAR Surgical Company (STAA)'s Post-Merger Standalone Valuation (Insider Monkey)
Jan-23-26 04:35PM	Staar Surgical, Dynatrace, and More Stocks See Action From Activist Investors (Barrons.com)
Jan-16-26 08:39PM	Staar Surgical, Alumis, and More Stocks See Action From Activist Investors (Barrons.com)
09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
08:02AM	Here Are Fridays Top Wall Street Analyst Research Calls: ConocoPhillips, Devon Energy, Garmin, Honeywell, HP, PepsiCo, Rocket Labs, Seagate, and More (24/7 Wall St.)
05:00AM	STAAR CEO exits after company rejects Alcon buyout (MedTech Dive)
Jan-15-26 11:04PM	STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
01:06PM	STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence (Benzinga)
08:30AM	STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement (Business Wire)
Jan-13-26 08:45AM	Mitsui Sumitomo Continues to Build WR Berkley Stake (24/7 Wall St.)
Jan-07-26 07:38AM	STAAR Surgical terminates Alcon merger agreement (Medical Device Network)
Jan-06-26 08:00PM	Alcon Terminates Agreement to Acquire STAAR Surgical (Business Wire) -6.91%
12:32PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:14PM	Exclusive: STAAR Surgical deal fails as shareholder support remains at around 30% (Investing.com)
09:52AM	Broadwood Partners Comments on STAAR Surgical Shareholders Rejection of the Companys Proposed Sale to Alcon (Business Wire)
08:47AM	STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders (Business Wire)
06:13AM	STAAR shareholders reject Alcons revised buyout offer (MedTech Dive)
Dec-19-25 03:51PM	Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for (Investing.com)
12:59PM	Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon (Business Wire)
11:45AM	Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders (Business Wire)
Dec-17-25 06:47PM	Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day (Investing.com) -7.22%
04:53PM	Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. (PR Newswire)
01:17PM	Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails (Business Wire)
10:55AM	STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value (Business Wire)
Dec-16-25 03:58PM	ISS recommends STAAR Surgical deal, but warns shareholders have reason to object (Investing.com) +5.26%
01:32PM	Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory (Business Wire)
09:12AM	Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction (Business Wire)
07:00AM	Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon (Business Wire)
Dec-15-25 06:35PM	Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote "FOR" Alcon Merger (Business Wire)
Dec-12-25 05:29PM	Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance against (Investing.com)
08:40AM	Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation "AGAINST" STAAR Surgical Sale to Alcon (Business Wire)
Dec-11-25 08:06PM	STAAR Surgical accuses activist Broadwood of misinformation campaign (Investing.com)
11:41AM	Why STAAR Surgical (STAA) Stock Is Up Today (StockStory)
09:47AM	STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process (Business Wire)
07:00AM	Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon (Business Wire)
Dec-10-25 01:34PM	STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon (Investing.com) -5.50%
07:05AM	Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer (Business Wire)
Dec-09-25 02:25PM	Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against (Investing.com) +7.84%
02:16PM	STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know (StockStory)
12:39PM	Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical (Business Wire)
12:00PM	What Makes Staar Surgical (STAA) a New Buy Stock (Zacks)
08:30AM	Alcon Announces Amended Merger Agreement with STAAR Surgical (Business Wire)
Dec-08-25 04:11PM	Why STAAR Surgical (STAA) Shares Are Plunging Today (StockStory) -7.25%
01:28PM	Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process (Business Wire)
08:16AM	Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
08:00AM	STAAR Surgical Announces Expiration of Go-Shop Period (Business Wire)
Dec-04-25 10:35PM	STAAR Surgical (NASDAQ:STAA) Q3 Earnings: Leading The Medical Devices & Supplies - Specialty Pack (StockStory)
Dec-03-25 12:02PM	Broadwood reiterates push for STAAR Surgical board shake-up as Alcon vote nears (Investing.com)
Dec-02-25 04:14PM	Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors (Business Wire)
Nov-26-25 03:34PM	Staar Surgical, Gold Royalty See Activist Action (Barrons.com)
Nov-18-25 04:15PM	STAAR Surgical reveals board dissent over amended Alcon deal ahead of vote (Investing.com)
Nov-12-25 02:35PM	Exclusive: Broadwood says Alcons earnings reveal STAAR bid came from weakness (Investing.com) -5.66%

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Executive VP & CFOMs. Deborah J. Andrews

Chief Development OfficerDr. Magda Michna Ph.D.

Director of Investor RelationsMs. Connie Johnson

VPMs. Kathleen Determann J.D.

Chief Medical OfficerDr. Scott D. Barnes M.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ANDREWS DEBORAH J	Chief Financial Officer & EVP	Aug 14 '26	Option Exercise	0.00	5,233	0	41,452	Aug 18 04:03 PM
Foust Warren	President and CEO	Aug 14 '26	Option Exercise	0.00	10,997	0	93,951	Aug 18 04:03 PM
Michna Magda	Chief Development Officer	Aug 14 '26	Option Exercise	4.36	6,599	28,798	43,599	Aug 18 04:03 PM
Butcher Arthur C	Director	Jun 18 '26	Option Exercise	0.00	5,341	0	9,549	Jun 22 04:05 PM
SILVERMAN LOU	Director	Jun 18 '26	Option Exercise	0.00	10,683	0	11,158	Jun 22 04:05 PM
Jiang Wei	Director	Jun 18 '26	Option Exercise	0.00	10,683	0	77,127	Jun 22 04:05 PM
Foust Warren	Interim Co-CEO and Pres. & COO	Mar 14 '26	Option Exercise	0.00	29,325	0	63,588	Mar 16 05:00 PM
Foust Warren	Interim Co-CEO and Pres. & COO	Mar 12 '26	Option Exercise	0.00	8,175	0	34,263	Mar 16 05:00 PM
Michna Magda	Chief Development Officer	Mar 14 '26	Option Exercise	0.00	17,595	0	36,001	Mar 16 05:00 PM
Michna Magda	Chief Development Officer	Mar 12 '26	Option Exercise	0.00	6,178	0	20,622	Mar 16 05:00 PM
BROADWOOD PARTNERS, L.P.	Director	Mar 13 '26	Buy	18.61	316,017	5,882,656	16,123,842	Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.	Director	Mar 12 '26	Buy	18.12	299,432	5,424,330	15,807,825	Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.	Director	Mar 11 '26	Buy	17.52	54,764	959,558	15,508,393	Mar 13 07:59 PM
Jiang Wei	Director	Jan 12 '26	Option Exercise	0.00	20,967	0	66,444	Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 09 '26	Buy	22.05	27,485	606,138	15,453,629	Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 06 '26	Buy	21.62	336,946	7,284,281	15,356,437	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 07 '26	Buy	22.00	66,467	1,462,301	15,422,904	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 08 '26	Buy	21.94	3,240	71,082	15,426,144	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 21 '25	Buy	27.86	797,486	22,218,837	15,019,491	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 20 '25	Buy	27.14	393,382	10,675,325	14,222,005	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 19 '25	Buy	26.42	309,132	8,166,155	13,828,623	Nov 21 09:55 PM
Jiang Wei	Director	Nov 12 '25	Option Exercise	0.00	20,967	0	45,477	Nov 14 06:00 PM

Open in Screener

LNSR

LENSAR Inc

8.20

Aug 19 • 4:27 AM ET +0.01 (0.12%)

Healthcare Medical Devices USA Micro NASD

Peers: BDMD SERA POAS RXST INGN LUCD MASS SENS SGHT TLSI

| Held by: VTI VXF IWC DFMC DFAS AVSC DCOR

Index	-
Market Cap	100.74M
Enterprise Value	103.34M
Income	15.51M
Sales	60.26M
Book/sh	1.21
Cash/sh	1.10
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	150
IPO	Oct 02, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	1.67
P/B	6.76
P/C	7.43
P/FCF	-
EV/EBITDA	-
EV/Sales	1.71
Quick Ratio	1.13
Current Ratio	2.39
Debt/Eq	0.08
LT Debt/Eq	0.06
Option/Short	Yes / Yes

EPS (ttm)	-0.33
EPS next Y	-0.33
EPS next Q	-0.14
EPS this Y	133.80%
EPS next Y	-134.02%
EPS next 5Y	-
EPS past 3/5Y	-13.51% -9.65%
Sales past 3/5Y	18.23% 17.24%
EPS Y/Y TTM	130.18%
Sales Y/Y TTM	3.26%
EPS Q/Q	167.73%
Sales Q/Q	18.37%
Earnings	Aug 13 BMO
EPS/Sales Surpr.	160.61% -6.58%

Insider Own	20.19%
Insider Trans	0.00%
Inst Own	45.90%
Inst Trans	-5.61%
ROA	22.16%
ROE	159.72%
ROIC	51.23%
Gross Margin	46.82%
Oper. Margin	-13.48%
Profit Margin	25.74%
SMA20	30.82%
SMA50	36.03%
SMA200	-3.33%
Trades

Shs Outstand	12.28M
Shs Float	9.80M
Short Float	4.60%
Short Ratio	4.14
Short Interest	0.45M
52W High	12.96 -36.73%
52W Low	4.95 65.66%
Volatility	7.80% 5.33%
ATR (14)	0.40
RSI (14)	79.29
Beta	0.97
Rel Volume	0.02
Avg Volume	108.86K
Volume	125

Perf Week	30.37%
Perf Month	42.36%
Perf Quarter	41.38%
Perf Half Y	-27.56%
Perf YTD	-29.49%
Perf Year	-34.40%
Perf 3Y	140.47%
Perf 5Y	4.59%
Perf 10Y	-
Recom	1.00
Target Price	11.00
Prev Close	8.19
Price	8.20
Change %	0.12%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-01-26	Upgrade	Lake Street	Hold → Buy	$10
Mar-18-26	Upgrade	BTIG Research	Neutral → Buy	$10
Feb-24-21	Initiated	SVB Leerink	Outperform	$20

Aug-13-26 07:07PM	LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge (GuruFocus.com) +31.48%
01:00PM	LENSAR, Inc. Q2 2026 Earnings Call Summary (Moby)
07:00AM	LENSAR Reports Second Quarter 2026 Results and Provides Business Update (GlobeNewswire)
Aug-12-26 09:30AM	Earnings To Watch: LENSAR Inc (LNSR) Q2 2026 -- GF Value Sees 13% Upside (GuruFocus.com)
Aug-06-26 08:00AM	LENSAR to Report Second Quarter 2026 Results on August 13th, 2026 (GlobeNewswire)
07:00AM	Loading…
May-08-26 07:00AM	LENSAR Reports First Quarter 2026 Results and Provides Business Update (GlobeNewswire) +7.84%
Apr-30-26 07:00AM	LENSAR to Report First Quarter 2026 Results on May 8, 2026 (GlobeNewswire)
Apr-03-26 09:00PM	LENSAR Inc (LNSR) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Apr-01-26 08:30AM	LENSAR, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-31-26 06:00AM	LENSAR Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update (GlobeNewswire)
Mar-30-26 09:18AM	Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2025 Result (GuruFocus.com)
Mar-17-26 09:33AM	BYND And LNSR Set The Tone Tuesday (GuruFocus.com) -32.85%
06:57AM	Alcon abandons effort to purchase LENSAR after FTC scrutiny (MedTech Dive)
Mar-16-26 04:57PM	Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement (Business Wire)
04:30PM	LENSAR Announces Termination of Merger Agreement with Alcon Research, LLC (GlobeNewswire)
05:00PM	Loading…
Feb-25-26 05:00PM	LENSAR Provides Update on Pending Acquisition by Alcon (GlobeNewswire)
Nov-06-25 07:00AM	LENSAR Reports Third Quarter 2025 Results and Provides Business Update (GlobeNewswire) -8.63%
Sep-02-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-07-25 07:00AM	LENSAR Reports Second Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Jul-01-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-02-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-08-25 07:00AM	LENSAR Reports First Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Apr-24-25 09:20AM	LENSAR: It Is All About The Contingent Value Right Now (Seeking Alpha)
Apr-10-25 01:59PM	Alcon: A Clear Vision, But Fully Valued (Seeking Alpha)
08:35AM	Is LENSAR (LNSR) a Deeply Undervalued Stock? (Insider Monkey)
Mar-25-25 09:00AM	Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit (TipRanks)
08:35AM	ALC Stock Rises Following the Merger Agreement With LENSAR (Zacks)
Mar-24-25 08:00AM	Alcon Agrees to Acquire LENSAR, Inc. (GlobeNewswire)
Mar-03-25 07:03PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-28-25 02:17AM	LENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com) +19.60%
07:00AM	Loading…
Feb-27-25 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update (GlobeNewswire) +14.78%
Feb-26-25 08:18AM	Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2024 Result (GuruFocus.com)
Feb-19-25 12:00PM	LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 (GlobeNewswire)
Feb-03-25 07:33PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.63%
Jan-02-25 06:08PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-09-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-26-24 08:00AM	LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day (GlobeNewswire)
Nov-08-24 02:14AM	LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion (GuruFocus.com) +7.42%
Nov-07-24 07:00AM	LENSAR Reports Third Quarter 2024 Results and Provides Business Update (GlobeNewswire) +17.24%
Nov-06-24 07:53AM	LENSAR Inc (LNSR) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-01-24 06:32PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.28% +8.92%
Oct-31-24 07:00AM	LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 (GlobeNewswire)
Oct-09-24 08:15AM	Lensar announces more than 1M procedures completed with cataract laser systems (TipRanks)
Oct-08-24 08:00AM	One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems (GlobeNewswire) +6.11%
Oct-01-24 06:25PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-04-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Aug-08-24 07:00AM	LENSAR Reports Second Quarter 2024 Results and Provides Business Update (Business Wire) -9.93%
Aug-07-24 07:00AM	LENSAR Announces Certification for the ALLY Adaptive Cataract Treatment System in the European Union (Business Wire) -7.90%
Aug-01-24 06:42PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
07:00AM	LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (Business Wire)
Jul-05-24 10:00AM	3 Under-$10 Stocks With the Potential to Make You a Millionaire (InvestorPlace)
Jul-02-24 05:50PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.80%
Jun-03-24 06:34PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.33%
May-23-24 08:00AM	LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
May-13-24 11:14AM	LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 11:57AM	LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +12.68%
07:00AM	LENSAR Reports First Quarter 2024 Results and Provides Business Update (Business Wire)
May-02-24 08:00AM	LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (Business Wire)
May-01-24 06:38PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-01-24 06:28PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-05-24 09:11AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.97%
Mar-04-24 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (Business Wire)
Mar-01-24 05:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-26-24 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024 (Business Wire)
Nov-12-23 09:38AM	LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 07:00AM	LENSAR Reports Third Quarter 2023 Results and Provides Business Update (Business Wire) +12.44%
Nov-02-23 08:03AM	LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (Business Wire) +5.12%
Aug-09-23 07:00AM	LENSAR Reports Second Quarter 2023 Results and Provides Business Update (Business Wire) +12.73%
Jul-24-23 07:00AM	LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups (Business Wire)
May-15-23 07:00AM	LENSAR Reports First Quarter 2023 Results and Provides Business Update (Business Wire) -9.45%
May-10-23 08:00AM	LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 (Business Wire)
Mar-20-23 03:05AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript (Insider Monkey) -10.98%
Mar-16-23 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update (Business Wire)
Mar-09-23 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 (Business Wire)
Feb-14-23 07:00AM	LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results (Business Wire)
Nov-22-22 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-09-22 07:00AM	LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -11.56%
Nov-02-22 08:00AM	LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022 (Business Wire)
Sep-08-22 07:00AM	LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU (Business Wire)
Aug-16-22 07:00AM	First Patients Treated with LENSARs® ALLY Adaptive Cataract Treatment System (Business Wire)
Aug-08-22 07:00AM	LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-01-22 08:00AM	LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022 (Business Wire)
Jun-13-22 07:00AM	LENSAR® Receives U.S. FDA Clearance of ALLY Adaptive Cataract Treatment System (Business Wire)
Jun-09-22 07:30AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
May-09-22 07:00AM	LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-02-22 08:00AM	LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 (Business Wire)
Apr-21-22 09:08AM	We're Not Very Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Rate (Simply Wall St.)
Mar-03-22 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) +6.34%
Mar-01-22 07:00AM	LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY (Business Wire)
Feb-28-22 04:01PM	LENSAR to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022 (Business Wire)
Feb-23-22 02:01AM	Should Now Consider Selling Your LENSAR (LNSR) Shares? (Insider Monkey)
Feb-10-22 08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Jan-04-22 08:00AM	LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference (Business Wire)
Dec-31-21 07:53AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
Nov-16-21 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-12-21 07:00AM	LENSAR Announces Poster Presentations at the American Academy of Ophthalmology (Business Wire)
Nov-08-21 07:00AM	LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Nov-01-21 08:00AM	LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021 (Business Wire)
Oct-02-21 10:32AM	We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth (Simply Wall St.)

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

PresidentMr. Nicholas T. Curtis

Chief Operating OfficerMr. Alan B. Connaughton

Interim CFO & Principal Financial Officer and SecretaryMr. Michael A. Rossi

Principal Accounting OfficerMs. Kendra W. Wong

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STAAB THOMAS R II	Officer	May 12 '26	Proposed Sale	5.75	850	4,888		May 12 01:12 PM
STAAB THOMAS R II	Chief Financial Officer	Mar 19 '26	Option Exercise	2.65	5,500	14,575	175,959	Mar 19 04:45 PM

STAA

Staar Surgical Co

LNSR

LENSAR Inc

Upgrade your Finviz experience